Veterinary Stents Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
The Global Veterinary Stents Market was valued at USD 45 million in 2024 and is estimated to grow at a CAGR of 6.7% to reach USD 85.3 million by 2034. The market is expanding due to the rising demand for minimally invasive treatments, growing awareness among pet owners, and ongoing advancements in veterinary healthcare. As the global pet population continues to increase, so does the need for advanced, less-invasive treatment options that ensure quicker recovery and fewer complications. Technological innovations, such as improvements in stent materials and placement techniques, are revolutionizing care for small animals, especially those requiring precision in surgeries for long-term functionality.
These developments, particularly the use of nitinol and biocompatible polymers in stents, have significantly improved the treatment of respiratory, vascular, and urinary conditions in animals. Veterinary professionals are now able to manage complex cases with fewer risks and more predictable recovery outcomes, making stenting procedures more widely accepted. With better access to enhanced fluoroscopic and endoscopic technology, veterinary hospitals and clinics are now more capable of providing these procedures, fostering broader adoption among general practices and specialized centers.
The airway stents segment led the market with USD 17.7 million in 2024. This dominance is linked to the increasing prevalence of respiratory issues in smaller dog breeds, particularly tracheal collapse, a condition that narrows the airway. New advancements in stent design, including self-expanding formats and biodegradable options, are effectively addressing the unique needs of small animals, minimizing both discomfort and complications. As pet owners and veterinarians increasingly favor less-invasive options, the demand for airway stents continues to rise.
In 2024, the dogs segment accounted for 60.5% of the market share. Chronic conditions such as airway collapse, vascular blockages, and urethral obstructions are more commonly diagnosed in dogs, ensuring steady demand for veterinary stents. Larger dog breeds often require vascular or urinary support, while smaller and toy breeds face more frequent airway-related complications, driving the use of these products.
North America represented 41.5% of the market share in 2024, supported by widespread pet ownership, heightened pet health awareness, and a growing inclination toward advanced veterinary treatments. The region benefits from a robust veterinary infrastructure, including specialty hospitals and emergency care centers equipped with state-of-the-art diagnostic and interventional tools. The availability of skilled professionals and advanced imaging techniques, such as fluoroscopy and CT scans, further enhances the accuracy of stent placement.
Key players in the market include Dextronix, EpiicVet, AbtVet (Stening Group), M.I. Tech, Infiniti Medical, UltraVet Medical Devices, Create Medic, and TaeWoong Medical. These companies are driving innovation in stent design, particularly with self-expanding and biodegradable materials tailored for various species and conditions. Collaborations with veterinary clinics and universities for clinical trials and training are helping brands expand their market presence, while strategic partnerships with distributors, direct outreach to veterinarians, and investments in digital marketing and telemedicine are strengthening their positions in the market.
These developments, particularly the use of nitinol and biocompatible polymers in stents, have significantly improved the treatment of respiratory, vascular, and urinary conditions in animals. Veterinary professionals are now able to manage complex cases with fewer risks and more predictable recovery outcomes, making stenting procedures more widely accepted. With better access to enhanced fluoroscopic and endoscopic technology, veterinary hospitals and clinics are now more capable of providing these procedures, fostering broader adoption among general practices and specialized centers.
The airway stents segment led the market with USD 17.7 million in 2024. This dominance is linked to the increasing prevalence of respiratory issues in smaller dog breeds, particularly tracheal collapse, a condition that narrows the airway. New advancements in stent design, including self-expanding formats and biodegradable options, are effectively addressing the unique needs of small animals, minimizing both discomfort and complications. As pet owners and veterinarians increasingly favor less-invasive options, the demand for airway stents continues to rise.
In 2024, the dogs segment accounted for 60.5% of the market share. Chronic conditions such as airway collapse, vascular blockages, and urethral obstructions are more commonly diagnosed in dogs, ensuring steady demand for veterinary stents. Larger dog breeds often require vascular or urinary support, while smaller and toy breeds face more frequent airway-related complications, driving the use of these products.
North America represented 41.5% of the market share in 2024, supported by widespread pet ownership, heightened pet health awareness, and a growing inclination toward advanced veterinary treatments. The region benefits from a robust veterinary infrastructure, including specialty hospitals and emergency care centers equipped with state-of-the-art diagnostic and interventional tools. The availability of skilled professionals and advanced imaging techniques, such as fluoroscopy and CT scans, further enhances the accuracy of stent placement.
Key players in the market include Dextronix, EpiicVet, AbtVet (Stening Group), M.I. Tech, Infiniti Medical, UltraVet Medical Devices, Create Medic, and TaeWoong Medical. These companies are driving innovation in stent design, particularly with self-expanding and biodegradable materials tailored for various species and conditions. Collaborations with veterinary clinics and universities for clinical trials and training are helping brands expand their market presence, while strategic partnerships with distributors, direct outreach to veterinarians, and investments in digital marketing and telemedicine are strengthening their positions in the market.
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising pet ownership
3.2.1.2 Prevalence of respiratory and urological disorders
3.2.1.3 Growing awareness of pet health and healthcare expenditure
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of veterinary stents and procedures
3.2.2.2 Risk of stent-related complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY PRODUCT, 2021 - 2034 ($ MN)
5.1 Key trends
5.2 Airway stents
5.3 Vascular stents
5.4 Urethral stents
5.5 Other stents
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY ANIMAL, 2021 - 2034 ($ MN)
6.1 Key trends
6.2 Dogs
6.3 Cats
6.4 Other animals
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 - 2034 ($ MN)
7.1 Key trends
7.2 Airway collapse
7.3 Vascular obstructions
7.4 Urinary tract obstructions
7.5 Other applications
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2021 - 2034 ($ MN)
8.1 Key trends
8.2 Nitinol
8.3 Biodegradable polymer
CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY END USE, 2021 - 2034 ($ MN)
9.1 Key trends
9.2 Veterinary hospitals and clinics
9.3 Other end use
CHAPTER 10 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 - 2034 ($ MN)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
CHAPTER 11 COMPANY PROFILES
11.1 AbtVet (Stening group)
11.2 Create Medic
11.3 Dextronix
11.4 EpiicVet
11.5 Infiniti Medical
11.6 M.I. Tech
11.7 TaeWoong Medical
11.8 UltraVet Medical Devices
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising pet ownership
3.2.1.2 Prevalence of respiratory and urological disorders
3.2.1.3 Growing awareness of pet health and healthcare expenditure
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of veterinary stents and procedures
3.2.2.2 Risk of stent-related complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY PRODUCT, 2021 - 2034 ($ MN)
5.1 Key trends
5.2 Airway stents
5.3 Vascular stents
5.4 Urethral stents
5.5 Other stents
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY ANIMAL, 2021 - 2034 ($ MN)
6.1 Key trends
6.2 Dogs
6.3 Cats
6.4 Other animals
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 - 2034 ($ MN)
7.1 Key trends
7.2 Airway collapse
7.3 Vascular obstructions
7.4 Urinary tract obstructions
7.5 Other applications
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2021 - 2034 ($ MN)
8.1 Key trends
8.2 Nitinol
8.3 Biodegradable polymer
CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY END USE, 2021 - 2034 ($ MN)
9.1 Key trends
9.2 Veterinary hospitals and clinics
9.3 Other end use
CHAPTER 10 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 - 2034 ($ MN)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
CHAPTER 11 COMPANY PROFILES
11.1 AbtVet (Stening group)
11.2 Create Medic
11.3 Dextronix
11.4 EpiicVet
11.5 Infiniti Medical
11.6 M.I. Tech
11.7 TaeWoong Medical
11.8 UltraVet Medical Devices
